InnovatiOnsdag seminar: The rise and fall of Pico Genomics

Pico Genomics developed a new method that improved upon previous methods to non-invasively discover prenatal chromosomal aberrations. However the results from the first clinical tests were below expectations and the company was discontinued.

Kasper Karlsson, one of the founders of Pico Genomics and a researcher at Karolinska Institutet, tells the story from being a promising start-up to liquidation and speculates on what could have been done differently. The seminar will be held in English.